Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
86.30
-4.50 (-4.96%)
At close: Mar 4, 2026
NSE:ARISTO Revenue
Aristo Bio-Tech and Lifescience had revenue of 2.56B INR in the half year ending September 30, 2025, with 93.07% growth. This brings the company's revenue in the last twelve months to 3.60B, up 10.39% year-over-year. In the fiscal year ending March 31, 2025, Aristo Bio-Tech and Lifescience had annual revenue of 3.18B with 29.76% growth.
Revenue (ttm)
3.60B
Revenue Growth
+10.39%
P/S Ratio
0.16
Revenue / Employee
54.61M
Employees
66
Market Cap
587.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.18B | 729.45M | 29.76% |
| Mar 31, 2024 | 2.45B | 272.92M | 12.53% |
| Mar 31, 2023 | 2.18B | 520.92M | 31.43% |
| Mar 31, 2022 | 1.66B | -14.55M | -0.87% |
| Mar 31, 2021 | 1.67B | -340.13M | -16.90% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Basant Agro Tech (India) | 5.38B |
| Shiva Global Agro Industries | 3.00B |
| Teesta Agro Industries | 2.33B |
| Aimco Pesticides | 1.77B |
| Anya Polytech & Fertilizers | 1.59B |
| Balaji Phosphates | 1.49B |
| The Phosphate Company | 1.42B |
| Ambey Laboratories | 1.33B |